DIA selects Basel to host 30th EuroMeeting
The Drug Information Association (DIA) announced Basel, Switzerland as the location for the 30th anniversary of its EuroMeeting, April 17-19, 2018.
The congress will focus on increased collaboration between the regulatory and the health technology assessment (HTA) / payer environment, and to reflect this area of increasing importance, a new steering committee structure, according to DIA.
Read the full release here.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
FDA Expands Farapulse PFA Approval to Persistent AF After Strong ADVANTAGE AF Trial Results
July 7th 2025Boston Scientific’s Farapulse Pulsed Field Ablation System is now approved for treating persistent atrial fibrillation, following 12-month data from the ADVANTAGE AF trial showing strong safety, high freedom from AF, and no major complications.
